Severe aortic stenosis (SAS), also known as heart valve failure, is a signal for danger—yet many patients may not realize it1,2

Rick, a real TAVR patient, speaking with a cardiologist


Patients who are referred for treatment often face a perilous race against the clock—1 in 10 symptomatic severe aortic stenosis patients can die within 5 weeks while awaiting treatment.3 Early referrals and intervention could prevent these deaths.

Don't let fixable become fatal. Refer your patients for an evaluation sooner.

Peer Perspectives:

Why is a prompt referral so important for patients with symptomatic severe aortic stenosis?

“Undertreatment is really in large part determined by underreferral for the evaluation for an aortic valve replacement to specialized heart valve teams.”

Sammy Elmariah, MD, MPH
Interventional Cardiologist
and Heart Valve Specialist
References: 1.Lancellotti P, Magne J, Dulgheru R, et al. Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol. 2018;3(11):1060-1068. 2.Redfors B, Pibarot P, Gillam LD, et al. Stress testing in asymptomatic aortic stenosis. Circulation. 2017;135(20):1956-1976. 3.Malaisrie SC, McDonald E, Kruse J, et al. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014;98(5):1564-1571. 4.Li SX, Patel NK, Flannery LD, et al. Trends in utilization of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2022;79(9):864-877. 5.Lindman BR, Lowenstern A. The alarm blares for undertreatment of aortic stenosis: how will we respond? J Am Coll Cardiol. 2022;79(9):878-881. 6.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705.

Patients and/or clinicians quoted on this website have received compensation from Edwards Lifesciences.